Distributors' 'mountain' of pills fueled opioid epidemic, W.Va. judge told
Reuters
Published May 03, 2021 06:06AM ET
Updated May 03, 2021 10:15AM ET
By Brendan Pierson
(Reuters) -A city and county in West Virginia launched their case against the three largest U.S. drug distributors at a widely anticipated trial on Monday, accusing them of fueling the opioid crisis that has resulted in nearly 500,000 overdose deaths in the United States over two decades.
"We intend to prove the simple truth that the distributor defendants sold a mountain of opioid pills into our community, fueling the opioid epidemic," Paul Farrell, a lawyer for the city of Huntington and Cabell County, said in his opening statement in Charleston, West Virginia.
Lawyers for the distributors - AmerisourceBergen (NYSE:ABC) Corp, McKesson Corp (NYSE:MCK) and Cardinal Health Inc (NYSE:CAH) - are expected to give their opening statements later in the day.
The companies have denied the claims, arguing they cannot be liable for distributing pills that were prescribed by doctors.
Huntington and Cabell, along with other West Virginia towns and counties, opted out of a proposed $26 billion nationwide settlement with the three distributors and drugmaker Johnson & Johnson (NYSE:JNJ).
A verdict in the trial, before U.S. District Judge David Faber, could help lay the groundwork for settlements in the sprawling nationwide litigation over the opioid crisis, which encompasses more than 3,300 lawsuits by local governments around the country against opioid manufacturers, distributors and pharmacies.
Opioids resulted in the overdose deaths of nearly 500,000 people in the United States from 1999 to 2019, according to the U.S. Centers for Disease Control and Prevention. West Virginia is among the hardest hit states, recording more opioid prescriptions and overdose deaths per capita than any other in 2018, according to data from the National Institutes of Health.
Another opioid trial is underway in a case brought by California counties against J&J and other drugmakers, and a trial in a case brought by New York counties is scheduled to begin next month.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.